April 14 (UPI) --Pfizer on Monday announced it is halting ... patients are likely to suffer recurrences of cancerous tumors. Health News // 11 hours ago Crib mattresses can release toxic chemicals ...

Pfizer had intended to move the drug into late-stage testing, but called it quits after a patient in a clinical trial experienced a potentially drug-related liver injury. The drugmaker Pfizer is ...

Pfizer will stop developing an obesity pill that has been closely watched by investors, a severe blow in its efforts to compete with blockbuster weight-loss shots from Novo Nordisk A/S and Eli ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...

In partnership with Ayala Healthcare Holdings Inc. (AC Health), the Inquirer management recently signed the “Working with Cancer” pledge to demonstrate the company’s commitment to support ...

The announcement sparked speculation that a number of health companies would be interested in buying the Pfizer business. These include GlaxoSmithKline, though it is already looking to buy ...

A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in a new app to support patients with atopic dermatitis, which will start rolling ...

Healthcare & Pharmaceuticalscategory· April 14, 2025 Pfizer ends development of weight ... 2025 Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy ...